Janus Henderson Group
WST icon

Janus Henderson Group’s West Pharmaceutical WST Stock Holding History

Janus Henderson Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Sell
8,172
-1,669
-17% -$415K ﹤0.01% 1335
2025
Q4 		$2.71M Buy
9,841
+142
+1% +$38.8K ﹤0.01% 1186
2025
Q3 		$2.55M Sell
9,699
-300
-3% -$72.9K ﹤0.01% 1216
2025
Q2 		$2.19M Sell
9,999
-523
-5% -$112K ﹤0.01% 1245
2025
Q1 		$2.34M Buy
10,522
+730
+7% +$201K ﹤0.01% 1196
2024
Q4 		$3.21M Sell
9,792
-434
-4% -$137K ﹤0.01% 1083
2024
Q3 		$3.07M Hold
10,226
– – ﹤0.01% 1093
2024
Q2 		$3.37M Sell
10,226
-281
-3% -$99.3K ﹤0.01% 1011
2024
Q1 		$4.15M Sell
10,507
-199
-2% -$73.6K ﹤0.01% 949
2023
Q4 		$3.77M Buy
10,706
+842
+9% +$298K ﹤0.01% 937
2023
Q3 		$3.7M Sell
9,864
-716
-7% -$277K ﹤0.01% 905
2023
Q2 		$4.04M Sell
10,580
-1,256
-11% -$449K ﹤0.01% 922
2023
Q1 		$4.1M Sell
11,836
-2,543
-18% -$743K ﹤0.01% 934
2022
Q4 		$3.38M Buy
14,379
+4,609
+47% +$1.09M ﹤0.01% 957
2022
Q3 		$2.41M Buy
9,770
+29
+0.3% +$8.84K ﹤0.01% 1217
2022
Q2 		$2.95M Sell
9,741
-678,657
-99% -$221M ﹤0.01% 957
2022
Q1 		$283M Sell
688,398
-190,464
-22% -$74.6M 0.14% 164
2021
Q4 		$412M Buy
878,862
+262,999
+43% +$113M 0.17% 141
2021
Q3 		$261M Buy
615,863
+46,003
+8% +$19.4M 0.11% 193
2021
Q2 		$205M Sell
569,860
-77,619
-12% -$25.6M 0.09% 232
2021
Q1 		$182M Sell
647,479
-40,094
-6% -$11.5M 0.08% 236
2020
Q4 		$195M Buy
687,573
+15,631
+2% +$4.39M 0.09% 222
2020
Q3 		$185M Buy
671,942
+43,155
+7% +$11.4M 0.1% 218
2020
Q2 		$143M Sell
628,787
-227,236
-27% -$44.6M 0.08% 248
2020
Q1 		$130M Sell
856,023
-92,403
-10% -$14.2M 0.09% 232
2019
Q4 		$143M Sell
948,426
-9,105
-1% -$1.33M 0.07% 280
2019
Q3 		$136M Buy
957,531
+41,266
+5% +$5.68M 0.07% 290
2019
Q2 		$115M Sell
916,265
-45,987
-5% -$5.43M 0.06% 340
2019
Q1 		$106M Buy
962,252
+46,338
+5% +$4.82M 0.06% 363
2018
Q4 		$89.8M Buy
915,914
+39,109
+4% +$4.24M 0.06% 372
2018
Q3 		$108M Buy
876,805
+1,082
+0.1% +$121K 0.06% 375
2018
Q2 		$87M Buy
875,723
+186,752
+27% +$17.2M 0.05% 410
2018
Q1 		$60.8M Buy
688,971
+66,513
+11% +$6.22M 0.04% 510
2017
Q4 		$61.4M Buy
622,458
+113,227
+22% +$11.1M 0.04% 491
2017
Q3 		$49M Buy
509,231
+315,115
+162% +$28.5M 0.03% 524
2017
Q2 		$18.3M Buy
+194,116
New +$17.9M 0.01% 757

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group's WST Position: Q1 2026 in Review

Janus Henderson Group reduced its West Pharmaceutical (WST) stake by 17% in Q1 2026, selling an estimated $415K and leaving 8,172 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Janus Henderson Group first reported a position in WST in Q2 2017 and has held it in 36 quarters since. The position peaked at $412M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Janus Henderson Group held 8,172 shares of West Pharmaceutical worth $2.05M as of Q1 2026.
  • Janus Henderson Group sold 1,669 West Pharmaceutical shares in Q1 2026, an estimated $415K.
  • West Pharmaceutical made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1335 holding.
  • Janus Henderson Group first reported a position in West Pharmaceutical in Q2 2017 and has held it in 36 quarters since.
  • Janus Henderson Group's West Pharmaceutical position peaked at $412M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.